Home  |  Contact

UniProtKB/Swiss-Prot P68871: Variant p.Val127Gly

Hemoglobin subunit beta
Gene: HBB
Variant information

Variant position:  127
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Valine (V) to Glycine (G) at position 127 (V127G, p.Val127Gly).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and hydrophobic (V) to glycine (G)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In B-THAL; Dhonburi/Neapolis; unstable.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  127
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  147
The length of the canonical sequence.

Location on the sequence:   LGNVLVCVLAHHFGKEFTPP  V QAAYQKVVAGVANALAHKYH
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH

Gorilla                       LGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH

Rhesus macaque                LGNVLVCVLAHHFGKEFTPQVQAAYQKVVAGVANALAHKYH

Chimpanzee                    LGNVLVCVLAHHFGKEFTPPVQAAYQKVVAGVANALAHKYH

Pig                           LGNVIVVVLARRLGHDFNPNVQAAFQKVVAGVANALAHKYH

Bovine                        LGNVLVVVLARNFGKEFTPVLQADFQKVVAGVANALAHRYH

Rabbit                        LGNVLVIVLSHHFGKEFTPQVQAAYQKVVAGVANALAHKYH

Sheep                         LGNVLVVVLARHHGNEFTPVLQADFQKVVAGVANALAHKYH

Cat                           LGNVLVCVLAHHFGHDFNPQVQAAFQKVVAGVANALAHKYH

Horse                         LGNVLVVVLARHFGKDFTPELQASYQKVVAGVANALAHKYH

Chicken                       LGDILIIVLAAHFSKDFTPECQAAWQKLVRVVAHALARKYH

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 2 – 147 Hemoglobin subunit beta
Binding site 144 – 144
Modified residue 145 – 145 N6-acetyllysine; alternate
Glycosylation 121 – 121 N-linked (Glc) (glycation) lysine
Glycosylation 145 – 145 N-linked (Glc) (glycation) lysine; alternate
Helix 125 – 143


Literature citations

Hemoglobin Dhonburi alpha 2 beta 2 126 (H4) Val-->Gly: a new unstable beta variant producing a beta-thalassemia intermedia phenotype in association with beta zero-thalassemia.
Bardakdjian-Michau J.; Fucharoen S.; Delanoe-Garin J.; Kister J.; Lacombe C.; Winichagoon P.; Blouquit Y.; Riou J.; Wasi P.; Galacteros F.;
Am. J. Hematol. 35:96-99(1990)
Cited for: VARIANT B-THAL GLY-127;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.